WNT2B and ovarian carcinoma: Wang et al reported that silencing Wnt2B can decrease the capacity of metastatic dissemination for ovarian cancer cells, and the decreased Wnt2B expression can inhibit cancer cell survival and promote cell apoptosis after chemotherapy treatment.33